Dr Rajur holds a PhD degree in synthetic organic chemistry and has enjoyed a distinguished career in the academic community and the pharmaceutical industry with a broad range of experience in medicinal chemistry and drug discovery. He has authored more than 35 papers in peer-reviewed journals and holds several US patents.
Dr. Rajur’s academic career includes appointments at the Southwestern Medical Center in Dallas, Boston College, Northeastern University, Massachusetts General Hospital and Harvard Medical School. In the industrial sector, he has held scientific and managerial positions at ArQule and Millipore Corporations. At ArQule, Dr. Rajur supervised collaborations with Bayer, Pfizer and Amersham Pharmacia Biosciences. Dr. Rajur also significantly contributed to ArQule’s internal drug discovery programs, specifically the ion channel, kinase and GPCR programs. Products co-developed by Dr. Rajur have been used in drug discovery efforts at Clonetech Laboratories in Palo Alto, CA.
Dr. Rajur’s expertise is with small molecule drug discovery, specifically targeted towards cancer, diabetes, antiviral and anti-infective therapeutics and the development of Antibody Drug Conjugates.
Dr. Kim received his PhD degree from New Mexico State University and then entered his postdoctoral appointment at Marion Merrell Dow. Dr. Kim served as Director of Chemistry at Aurigene Discovery Technologies, where he directed all global partnered chemistry programs. Prior to that, as Project Leader at Molecumetics, he managed five partnered projects, company internal projects, and High Throughput Organic Synthesis (Automation Synthesis) for collaborations with more than $10M revenue. Dr. Kim has authored more than 40 technical articles and books and holds ten US Patents.
Dr. James Siedlecki
Sr. Director of Research & Development and external alliances
Dr. James Siedlecki received his PhD degree from North Carolina State University conducting research with Professor Russell J. Linderman. Dr. Siedlecki’s Industrial career includes appointments at Arqule Inc, Cubist Pharmaceuticals, ActiveBiotics, and AstraZeneca. Dr. Siedlecki served as Sr.Director of Medicinal Chemistry at Syndexa pharmaceuticals where he managed endoplasmic reticulum stress modulator and JNK inhibitor programs. Dr. Siedlecki Managed internal Ph.D. level FTE’s and FTE’s at CRO in China. Russia, and US. Dr. Siedlecki recently served as the sr. director of chemistry at ImmuneXcite Inc., where established internal Medicinal chemistry department and directed research efforts that led to oligosaccride antibody conjugates as novel immunotherapy drugs and anti-infectives. Dr. Siedlecki has authored more than 30 technical articles and holds eleven US patents.
Naveen graduated from Marshal School of Business management at University of Southern California, majoring in economics, health care finance and business development. Mr. Rajur has gained financial experience at a Private Equity Search Fund Crest Point LLC in Pasadena and in Wealth Management at Morgan Stanley in Long Beach California. He is serving as CreaGen Inc.’s Business Development Manager.
Chief Financial officer
Vimal Graduated from Bentley University majoring in Accounting and completed his MBA from Suffolk University. He has 25 years of experience in finance and accounting and he is a member of the American Institute of Certified Public Accountants and member of the Massachusetts Society of Certified Public Accountants
Ms. Anny Chum
Director of Operations & Administration
Ms Anny Chum is CreaGen’s Director of Operations & Administration. Holding Associates Degrees in both Business Administration and Biotechnology from Middlesex Community College, Anny brings years of technical, operational and administration expertise to CreaGen. She coordinates daily operations, streamline management system, monitor budget and supervise CRO projects and report to upper management.
A dedicated worker and enthusiastic team player, Anny also supports C2I Accelerators (www.creagenincubator.com) technical and research efforts and oversees day-to-day administrative tasks.
Mr. Vimal Raheja, MBA, CPA, Financial Advisor
Mr. Raheja received his BA degree from the University of Massachusetts, Amherst, MA, his MBA degree from Suffolk University, Boston, MA, and his MSA degree from Bentley College, Waltham, MA. He is a member of the American Institute of Certified Public Accountants and also a member of the Massachusetts Society of Certified Public Accountants.